Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Evotec And Bristol Myers Squibb Expand Molecular Glue Degrader Pipeline, Triggering $75M In Total Performance-Based Payments

Author: Benzinga Newsdesk | August 13, 2024 02:24am

Key scientific achievements drive the expansion of the pipeline of molecular glue degraders
Performance-based and programme-based payments of in total US$ 75 m to Evotec

Posted In: BMY EVO